Edition:
United States

Delcath Systems Inc (DCTH.PK)

DCTH.PK on OTC Markets Group

0.00USD
14 Sep 2017
Change (% chg)

-- (--)
Prev Close
$0.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,958,712
52-wk High
$4.31
52-wk Low
$0.02

Latest Key Developments (Source: Significant Developments)

Delcath announces proposed public offering of common stock and warrants
Thursday, 29 Sep 2016 05:40pm EDT 

Delcath Systems Inc : Delcath announces proposed public offering of common stock and warrants .Intends to use net proceeds for funding of clinical trials, commercialization of its products, obtaining regulatory approvals etc.  Full Article

Delcath posts Q2 loss of $4.41/share
Tuesday, 16 Aug 2016 08:00am EDT 

Delcath Systems Inc: Delcath announces second quarter financial results . Qtrly loss per share $4.41 . Q2 revenue $500,000 .Delcath believes it has sufficient capital to fund its operating activities through end of 2017.  Full Article

Delcath Systems Inc announces initiation of Phase 3 trial of Melphalan/HDS System
Wednesday, 20 Jan 2016 08:00am EST 

Delcath Systems Inc:Announces the initiation of a Phase 3 clinical trial of Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) for the treatment of patients with hepatic dominant ocular melanoma (OM).Says moffitt cancer center begins patient enrollment in focus trial; study results to support u.s. new drug application.  Full Article

BRIEF-Delcath Systems CEO issues letter to stockholders providing business update

* Delcath Systems - CEO issued letter to stockholders providing business update, "rationale for company's recent actions to preserve access to capital​"